T he first paper to describe AIDS reported that patients had very few CD4 + T cells in their blood 1 . Depletion of this crucial subset of immune cells is now known to be a key feature of the disease, but the mechanisms responsible for their loss have remained unclear. Particularly mysterious has been the observation that HIV1 infection results not only in the death of activated, productively infected CD4 + T cells (those in which the virus successfully replicates) but also in 'bystander' CD4 + T cells that do not seem to be infected. On page 509 of this issue, Doitsh et al. 2 show that most CD4 + T cells depleted during HIV1 infection are abortively infected cells that die through pyroptosis -a celldeath mechanism that is distinct from apoptosis and necroptosis 3 . HIV1 replication in productively infected CD4 + T cells kills them quickly, within one to two days 4, 5 . This direct killing is apparent during acute infection, when virus levels are high and massive depletion of CD4 + T cells occurs in the gastrointestinal tract 6 . However, in the absence of treatment, most of the CD4 + Tcell loss associated with the infection occurs during the prolonged asymptomatic phase between the acute stage and the development of AIDS. During this period, the number of activated, productively infected CD4 + T cells is low, suggesting that the infection may promote death of quiescent (nonactivated) cells.
Levels of immune activation are high in untreated HIV1 infection, perhaps reflecting the translocation of microbial products across a compromised gastrointestinal barrier 7 , and it is commonly assumed that this immune activation is responsible for CD4 + Tcell loss. Perhaps the best evidence for this comes from studies of simian immunodeficiency virus infections, in which there is high virus repli cation, but little immune activation or CD4 . Only the effects of the former can be predicted in a deterministic way by climate models, with natural variability appearing as 'noise' in the climatemodel simulations. Second, sea ice is one of the most challenging elements of the Earth system to model. The rate at which it forms or melts is controlled by the small difference between large fluxes of heat from the atmosphere and the ocean, and its distribution is strongly influenced by winds and ocean currents. Small biases in the models' representation of the atmosphere or ocean can thus translate into large errors in modelled sea ice.
Although accurate modelling of Antarctic seaice trends will require a realistic representa tion of the processes connect ing Atlantic SSTs and Antarctic winds, this might not be suffi cient. Given the importance of Antarctic sea ice to the South ern Ocean marine eco system, and its role in driving global ocean circulation by the pro duction of ocean bottom water, understanding its behaviour and improving its representa tion in climate models must remain a high priority for climate scientists. ■ 
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HIV
Not-so-innocent bystanders
The discovery that most CD4 + T cells killed during HIV infection die through a process known as pyroptosis may provide long-sought explanations for HIV-associated T-cell depletion and inflammation. See Article p.509
Tcell depletion 8 . Nevertheless, the mechanis tic link between immune activation and CD4 + Tcell depletion has remained unclear.
Doitsh and colleagues suggest that this link may lie in the manner of cell death. Using cul tures of human cells isolated from the spleen or tonsils, they demonstrate that more than 95% of CD4 + T cells that die following HIV1 infec tion are quiescent cells that undergo pyrop tosis. Only a small proportion of the dying cells were activated, productively infected CD4 + T cells undergoing apoptosis (Fig. 1) . Apoptosis depends on the activation of the cellsignalling molecule caspase3, whereas pyroptosis is triggered by inflammasome activated caspase1. Inflammasomes are multi protein cytoplasmic complexes that integrate pathogentriggered signalling pathways and then recruit and activate inflammatory cas pase molecules. Pyroptosis results in lysis of the cell and release of the cytoplasmic con tents into the extracellular space, and is highly inflammatory.
Productive HIV1 infection involves the virus binding to the Tcell surface and enter ing the cell. There, the viral RNA is reverse transcribed to DNA and integrated into the hostcell genome, resulting in replication of the virus. If this process is aborted before integra tion and viral replication occur, the infection is termed nonproductive. Doitsh and colleagues previously demonstrated 9 that there is selective depletion of CD4 + T cells in which incomplete viral DNA transcripts accumulate following abortive infection. The same research group also recently identified interferonγinducible protein 16 (IFI16) as the hostcell DNA sensor that triggers this cell death 10 . To verify that most CD4 + Tcell depletion occurring during HIV1 infection is medi ated by pyroptosis, the authors treated cells with inhibitors of caspase3 or caspase6 (important in apoptosis), or of receptorinter acting protein kinase enzymes (important in necroptosis), and found that these treatments did not prevent most of the CD4 + Tcell loss. Also consistent with pyroptosis and the associ ated release of intracellular contents into the extracellular milieu was the presence of the cytoplasmic enzyme lactate dehydrogenase in the cellculture supernatants. In vivo evi dence for pyroptosis came from the detection of caspase1 in quiescent CD4 + T cells in the paracortical zone that surrounds the region of activated CD4 + T and B cells in HIV1infected lymphnode tissues. The authors did not detect caspase1 in the zone of activated CD4 + T cells or in uninfected tissue.
Caspase1 activation is known 11, 12 to induce secretion of the highly inflammatory cytokine proteins interleukin1β (IL1β) and IL18, which contribute to inflammatory condi tions such as atherosclerosis and metabolic syndromes [11] [12] [13] [14] . Doitsh and colleagues show that IL1β release also occurs after infection with HIV1, and that this requires caspase1 activation (Fig. 1) . Finally, the authors show that pyroptosis induced by HIV1 can be pre vented with VX765, a caspase1 inhibitor that has previously been tested in people with chronic epilepsy and psoriasis, and found to be safe and well tolerated. VX765 treatment inhibited caspase1 activation, IL1β secretion and CD4 + Tcell death in HIV1infected cell cultures.
These findings raise the possibility of reduc ing immune activation and inflammation in response to chronic viral infections through caspase1 inhibition. The research also sug gests two new approaches to improve HIV1 therapy: the use of antiretroviral agents that act early in the viral life cycle to block abor tive infection, and the use of agents that inhibit caspase1. Combination therapy with multiple classes of antiretroviral drugs is the standard of care for patients infected with HIV1, and this therapy effectively suppresses viral replication. Suppression of caspase1 activation may not be necessary if combination therapy prevents abortive infection as well.
Although Doitsh et al. do not report IL18 levels in their study, this cytokine is generally produced along with IL1β after inflamma some activation, and elevated levels are associ ated with inflammatory conditions [13] [14] [15] . Serum IL18 levels, which are known to be high in HIV1 infection, are reduced by anti retroviral therapy 14, 15 . Thus, it remains to be seen whether caspase1 inhibitors will add to exist ing antiretroviral therapy for the treatment of HIV1 infection. Either way, the implication of pyroptosis in CD4 + Tcell depletion is a new explanation for this 30yearold mystery in HIV1 pathogenesis. ■ 2 show that most CD4 + Tcell deaths result from caspase1mediated pyroptosis in nonactivated (quiescent) CD4 + T cells that have undergone abortive infection, during which incomplete viral DNA transcripts remain in the cells. These transcripts are sensed by the cellular DNA sensor IFI16, which leads to caspase1 activation, resulting in the secretion of the highly inflammatory cellsignalling molecule IL1β and pyroptosis.
